Showing results (141-150 of 176) with videos related to
Sort By:
Pageof 18
Journal of Gastroenterology and Hepatology|July 21, 2023
Correlation between serum pro-inflammatory cytokine levels and the prognosis of the patients with acute liver failureSerami Murakami, Takuro Uchida, Michio Imamura, et al.Journal of Gastroenterology|October 15, 2020
PNPLA3 and HLA-DQB1 polymorphisms are associated with hepatocellular carcinoma after hepatitis C virus eradicationDaiki Miki, Tomoyuki Akita, Akemi Kurisu, et al.Gut|January 17, 2013
Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric miceNiu Shi, Nobuhiko Hiraga, Michio Imamura, et al.Journal of Viral Hepatitis|June 9, 2021
Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patientsYuno Nishida, Michio Imamura, Yuji Teraoka, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 7, 2026
Efficacy and Safety of Second-Line Lenvatinib After First-Line Durvalumab Plus Tremelimumab in Unresectable Hepatocellular CarcinomaRyoichi Miura, Tomokazu Kawaoka, Saki Sueda, et al.Biochemical and Biophysical Research Communications|May 1, 2021
Novel drug resistance-associated substitutions against pibrentasvir emerged in genotype 1b hepatitis C virus-infected human hepatocyte transplanted miceKazuki Ohya, Michio Imamura, Yuji Teraoka, et al.The Journal of General Virology|June 15, 2019
Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized miceMitsutaka Osawa, Takuro Uchida, Michio Imamura, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 3, 2014
Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis CYuko Nagaoki, Michio Imamura, Yoshiiku Kawakami, et al.Journal of Gastroenterology and Hepatology|January 3, 2020
Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy casesKana Daijo, Takashi Nakahara, Yuki Inagaki, et al.Journal of Medical Virology|June 29, 2017
Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patientsHiromi Kan, Michio Imamura, Yoshiiku Kawakami, et al.Pageof 18